These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17089700)

  • 1. Aerosolization potential of cyclodextrins--influence of the operating conditions.
    Le VN; Leterme P; Gayot A; Flament MP
    PDA J Pharm Sci Technol; 2006; 60(5):314-22. PubMed ID: 17089700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and in vitro evaluation of the formoterol/cyclodextrin complex for pulmonary administration by nebulization.
    Thi TH; Azaroual N; Flament MP
    Eur J Pharm Biopharm; 2009 May; 72(1):214-8. PubMed ID: 19010412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers.
    Steckel H; Eskandar F
    Eur J Pharm Sci; 2003 Aug; 19(5):443-55. PubMed ID: 12907295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.
    McCallion ON; Taylor KM; Thomas M; Taylor AJ
    Pharm Res; 1995 Nov; 12(11):1682-8. PubMed ID: 8592670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrins as a potential carrier in drug nebulization.
    Evrard B; Bertholet P; Gueders M; Flament MP; Piel G; Delattre L; Gayot A; Leterme P; Foidart JM; Cataldo D
    J Control Release; 2004 May; 96(3):403-10. PubMed ID: 15120897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of fluid physicochemical properties on vibrating-mesh nebulization.
    Ghazanfari T; Elhissi AM; Ding Z; Taylor KM
    Int J Pharm; 2007 Jul; 339(1-2):103-11. PubMed ID: 17451896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nebulization of active pharmaceutical ingredients with the eFlow(®) rapid: impact of formulation variables on aerodynamic characteristics.
    Beck-Broichsitter M; Prüfer N; Oesterheld N; Seeger W; Schmehl T
    J Pharm Sci; 2014 Aug; 103(8):2585-9. PubMed ID: 24986144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical aspects and efficiency of albuterol nebulization: comparison of three aerosol types in an in vitro pediatric model.
    Sidler-Moix AL; Di Paolo ER; Dolci U; Berger-Gryllaki M; Cotting J; Pannatier A
    Respir Care; 2015 Jan; 60(1):38-46. PubMed ID: 25516995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers.
    Beck-Broichsitter M; Kleimann P; Schmehl T; Betz T; Bakowsky U; Kissel T; Seeger W
    Eur J Pharm Biopharm; 2012 Oct; 82(2):272-80. PubMed ID: 22820646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical stability and aerosol properties of liposomes delivered using an air-jet nebulizer and a novel micropump device with large mesh apertures.
    Elhissi AM; Faizi M; Naji WF; Gill HS; Taylor KM
    Int J Pharm; 2007 Apr; 334(1-2):62-70. PubMed ID: 17123757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration.
    Phipps PR; Gonda I
    Chest; 1990 Jun; 97(6):1327-32. PubMed ID: 2347217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cryoprotectants on the stability and aerosol performance of nebulized aviscumine, a 57-kDa protein.
    Steckel H; Eskandar F; Witthohn K
    Eur J Pharm Biopharm; 2003 Jul; 56(1):11-21. PubMed ID: 12837476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.
    Le Brun PP; de Boer AH; Gjaltema D; Hagedoorn P; Heijerman HG; Frijlink HW
    Int J Pharm; 1999 Nov; 189(2):205-14. PubMed ID: 10536249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of nebulizer type with different pediatric aerosol masks on drug deposition in a model of a spontaneously breathing small child.
    Lin HL; Wan GH; Chen YH; Fink JB; Liu WQ; Liu KY
    Respir Care; 2012 Nov; 57(11):1894-900. PubMed ID: 22418694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions.
    Beck-Broichsitter M; Knuedeler MC; Oesterheld N; Seeger W; Schmehl T
    Int J Pharm; 2014 Jan; 459(1-2):23-9. PubMed ID: 24286921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design principles of liquid nebulization devices currently in use.
    Rau JL
    Respir Care; 2002 Nov; 47(11):1257-75; discussion 1275-8. PubMed ID: 12425742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical properties of antibiotic aerosols produced by jet and ultrasonic nebulizers.
    Takanami C; Goto Y
    J Aerosol Med; 1990; 3(1):45-52. PubMed ID: 10147674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense oligonucleotides and their technical suitability to nebulization.
    Seidl LL; Moog R; Graeser KA
    Int J Pharm; 2024 Aug; 661():124390. PubMed ID: 38936443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.
    Sidler-Moix AL; Dolci U; Berger-Gryllaki M; Pannatier A; Cotting J; Di Paolo ER
    Pediatr Crit Care Med; 2013 Feb; 14(2):e98-102. PubMed ID: 23287904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.
    Elhissi AM; Karnam KK; Danesh-Azari MR; Gill HS; Taylor KM
    J Pharm Pharmacol; 2006 Jul; 58(7):887-94. PubMed ID: 16805947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.